ClinicalTrialsFinder

Siewert Type I Adenocarcinoma of Esophagogastric Junction Clinical Trials in Cleveland, Ohio

1 recruitingCleveland, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 2

Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma

Siewert Type II Adenocarcinoma of Esophagogastric JunctionAdenocarcinoma EsophagusLocally Advanced Adenocarcinoma+1 more
Sakti Chakrabarti25 enrolled1 locationNCT06044311